DNMT3A and the impact on the course of AML – Hagop Kantarjian, MD

Hagop Kantarjian, MD of MD Anderson Cancer Center discusses DNMT3A and the impact on the course of AML at the Scripps 36th Annual Conference: Clinical Hematology and Oncology in San Diego.